BGR GOVERNMENT AFFAIRS for AMGEN INC.
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Provide advice and strategic counsel with regard to regulations that could impact biopharmaceutical manufacturers generally and Amgen specifically, including Medicare Part D, Medicare Part B, Health Care Reform, Medicaid, 340b, FDA regulatory issues, and corporate tax reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID BOYER | See prior filing |
| BRENT ALAN DEL MONTE | See prior filing |
| RYAN LONG | See prior filing |
| DANIEL R MURPHY | COS Sec of HUD |
| ROBERT WOOD | See prior filing |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.